Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genome-wide association study of SSRI/SNRI-induced sexual dysfunction in a Japanese cohort with major depression.

Psychiatry research - 15 Aug 2012

Kurose Kouichi, Hiratsuka Kazuyuki, Ishiwata Kazuya, Nishikawa Jun, Nonen Shinpei, Azuma Junichi, Kato Masaki, Wakeno Masataka, Okugawa Gaku, Kinoshita Toshihiko, Kurosawa Toru, Hasegawa Ryuichi, Saito Yoshiro

Abstract excerpt

Sexual dysfunction is a major side effect of selective serotonin reuptake inhibitors (SSRIs) and serotonin-noradrenaline reuptake inhibitors (SNRIs). We conducted a genome-wide association study to identify the genetic factors contributing to the risk of SSRI/SNRI-induced sexual dysfunction by testing 186 320 single nucleotide polymorphism (SNP) markers in a cohort of 201 Japanese major depression patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cohort Studies
Share to Cyclopropanes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Depressive Disorder, Major

Share to Fluvoxamine

Share to GPI-Linked Proteins

Share to Neural Cell Adhesion Molecules

Share to Paroxetine

Share to Selective Serotonin Reuptake Inhibitors

Source

Identifiers

PMID: 22445761
DOI: 10.1016/j.psychres.2012.01.023

Genes

MDGA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genome-wide association study of SSRI/SNRI-induced sexual dysfunction in a Japanese cohort with major depression.PMID 22445761Read ↗

Association between 5HT2A polymorphism and selective serotonin re-uptake inhibitor (SSRI)-induced sexual desire disorder (SDD) among Malaysian women.Semantic proximity Read ↗

Female sexual dysfunction in patients with major depressive disorder (MDD) treated with selective serotonin reuptake inhibitor (SSRI) and its association with serotonin 2A-1438 G/A single nucleotide polymorphisms.Semantic proximity Read ↗

Genetic and clinical predictors of sexual dysfunction in citalopram-treated depressed patients.Semantic proximity Read ↗

A genome-wide association study of female sexual dysfunction.Semantic proximity Read ↗

Sexual dysfunction associated with major depressive disorder and antidepressant treatment.Semantic proximity Read ↗

Dissecting the genetic association between abnormal sperm parameters and depression: a transcriptome-wide analysis of 157 participants.Semantic proximity Read ↗

HTR2A is associated with SSRI response in major depressive disorder in a Japanese cohort.Semantic proximity Read ↗

Pharmacogenetics of glutamate system genes and SSRI-associated sexual dysfunction.Semantic proximity Read ↗

Association between serotonin 2A receptor (HTR2A), serotonin transporter (SLC6A4) and brain-derived neurotrophic factor (BDNF) gene polymorphisms and citalopram/sertraline induced sexual dysfunction in MDD patients.Semantic proximity Read ↗

Pharmacogenetics and pharmacogenomics of sexual dysfunction: current status, gaps and potential applications.Semantic proximity Read ↗

A genome-wide association study of escitalopram treatment outcomes in patients with major depressive disorder.Semantic proximity Read ↗

Association analysis of SIGMAR1 with major depressive disorder and SSRI response.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.